Disc Medicine shares rose about 50% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
A share-price jump by itself does not show what changed inside Disc Medicine. The story gives no reason for the move or company update, so it does not change how we read the company's business outlook.
DataMEDS AI shares rose about 20% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
Virax Biolabs Group shares rose about 17% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
Alaunos Therapeutics shares rose about 17% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
Akari Therapeutics shares rose about 13% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
Rapport Therapeutics shares rose about 12% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
Follow Disc Medicine (IRON) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IRON